Send us a Message

Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   


The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (

Term:retinopathy incidence/prevalence measurement
go back to main search page
Accession:CMO:0002454 term browser browse the term
Definition:Any measurement in which the number of individuals in a study population that display retinopathy at a point in time or develop retinopathy within a determined period of time are compared to the total number of individuals in the study population. Often expressed as a percentage but could be expressed as a ratio. Retinopathy is a noninflammatory degenerative disease of the retina.

show annotations for term's descendants           Sort by:
percentage of study population developing retinopathy during a period of time term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Arrd1 Age-related retinal degeneration QTL 1 IDA RGD PMID:22300709 RGD:7794750 NCBI chr 1:100,357,752...183,970,443 JBrowse link
Q Arrd2 Age-related retinal degeneration QTL 2 IDA RGD PMID:22300709 RGD:7794750 NCBI chr 1:183,970,203...243,914,901 JBrowse link

Term paths to the root